| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Bożena Adamczyk | Q89261528 |
| Monika Adamczyk-Sowa | Q90194477 | ||
| P2860 | cites work | Free radicals and antioxidants in normal physiological functions and human disease | Q21710698 |
| In vivo and in vitro genetic evidence of involvement of neuregulin 1 in immune system dysregulation | Q24610713 | ||
| Anti-acrolein treatment improves behavioral outcome and alleviates myelin damage in experimental autoimmune enchephalomyelitis mouse | Q24630119 | ||
| Free radicals: properties, sources, targets, and their implication in various diseases | Q27000071 | ||
| Tracking CNS and systemic sources of oxidative stress during the course of chronic neuroinflammation | Q27322415 | ||
| Plasmatic oxidative stress biomarkers in multiple sclerosis: relation with clinical and demographic characteristics | Q44848364 | ||
| Modulation of oxidative stress, apoptosis, and calcium entry in leukocytes of patients with multiple sclerosis by Hypericum perforatum | Q44912998 | ||
| Opposite regulation of the mitochondrial apoptotic pathway by C2-ceramide and PACAP through a MAP-kinase-dependent mechanism in cerebellar granule cells | Q45166159 | ||
| The antioxidant idebenone fails to prevent or attenuate chronic experimental autoimmune encephalomyelitis in the mouse | Q45895784 | ||
| Coenzyme Q10 supplementation reduces oxidative stress and increases antioxidant enzyme activity in patients with relapsing-remitting multiple sclerosis. | Q46078160 | ||
| Ozone Therapy in Ethidium Bromide-Induced Demyelination in Rats: Possible Protective Effect | Q46525864 | ||
| Evidence of extensive RNA oxidation in normal appearing cortex of multiple sclerosis brain | Q46618645 | ||
| Anti-inflammatory effects and antioxidant activity of dihydroasparagusic acid in lipopolysaccharide-activated microglial cells | Q46635906 | ||
| CCL11 enhances excitotoxic neuronal death by producing reactive oxygen species in microglia | Q46699381 | ||
| Mitoxantrone-induced suicidal erythrocyte death | Q46810020 | ||
| Involvement of nitric oxide in improving stress-induced behavioural alteration by glatiramer acetate treatment in female BALB/c mice. | Q46817518 | ||
| Markers of oxidative stress in plasma and saliva in patients with multiple sclerosis | Q46826911 | ||
| Hydralazine inhibits compression and acrolein-mediated injuries in ex vivo spinal cord | Q46905314 | ||
| Evaluation of lovastatin effects on expression of anti-apoptotic Nrf2 and PGC-1α genes in neural stem cells treated with hydrogen peroxide. | Q46951155 | ||
| Upregulation of immunomodulatory molecules by matrine treatment in experimental autoimmune encephalomyelitis | Q46955354 | ||
| Custom cerium oxide nanoparticles protect against a free radical mediated autoimmune degenerative disease in the brain | Q46968494 | ||
| Decreased urinary level of melatonin as a marker of disease severity in patients with multiple sclerosis | Q47574569 | ||
| Effect of natalizumab on oxidative damage biomarkers in relapsing-remitting multiple sclerosis | Q47768496 | ||
| Influence of melatonin supplementation on serum antioxidative properties and impact of the quality of life in multiple sclerosis patients | Q48033298 | ||
| Dimethyl fumarate activates the prostaglandin EP2 receptor and stimulates cAMP signaling in human peripheral blood mononuclear cells | Q48056054 | ||
| Demyelination: the role of reactive oxygen and nitrogen species | Q48283279 | ||
| Isoforms of mammalian peroxiredoxin that reduce peroxides in presence of thioredoxin | Q48299225 | ||
| Oligodendrocyte progenitors are present in the normal adult human CNS and in the lesions of multiple sclerosis | Q48316974 | ||
| Dimethylfumarate alleviates early brain injury and secondary cognitive deficits after experimental subarachnoid hemorrhage via activation of Keap1-Nrf2-ARE system | Q48363740 | ||
| Isoprostanes in clinically isolated syndrome and early multiple sclerosis as biomarkers of tissue damage and predictors of clinical course. | Q48400649 | ||
| Appearance of superoxide anion radical in cerebral extracellular space during increased prostaglandin synthesis in cats | Q48477188 | ||
| Cerebrospinal fluid and serum uric acid levels in patients with multiple sclerosis. | Q48586779 | ||
| Interplay of cannabinoid 2 (CB2) receptors with nitric oxide synthases, oxidative and nitrative stress, and cell death during remote neurodegeneration | Q48638028 | ||
| Interleukin-1β causes synaptic hyperexcitability in multiple sclerosis | Q48693638 | ||
| Protective Effect of Dimethyl Fumarate on an Oxidative Stress Model Induced by Sodium Nitroprusside in Mice | Q48701678 | ||
| Oxidative modification of patient's plasma proteins and its role in pathogenesis of multiple sclerosis | Q48825272 | ||
| Cytokine toxicity to oligodendrocyte precursors is mediated by iron | Q48843970 | ||
| Sulforaphane ameliorates the development of experimental autoimmune encephalomyelitis by antagonizing oxidative stress and Th17-related inflammation in mice | Q48938369 | ||
| Comparative Neuroregenerative Effects of C-Phycocyanin and IFN-Beta in a Model of Multiple Sclerosis in Mice | Q50239453 | ||
| Melatonin reduces oxidative stress in the erythrocytes of multiple sclerosis patients with secondary progressive clinical course. | Q50493390 | ||
| Genetic, Immune-Inflammatory, and Oxidative Stress Biomarkers as Predictors for Disability and Disease Progression in Multiple Sclerosis. | Q50945427 | ||
| Elevated melatonin levels in natalizumab-treated female patients with relapsing-remitting multiple sclerosis: relationship to oxidative stress. | Q51157176 | ||
| Serum paraoxonase and arylesterase activity and oxidative status in patients with multiple sclerosis. | Q51243760 | ||
| Effect of lipoic acid consumption on oxidative stress among multiple sclerosis patients: a randomized controlled clinical trial. | Q51343458 | ||
| Oligodendrocyte precursor cells in the demyelinated multiple sclerosis spinal cord. | Q52046430 | ||
| Fingolimod protects against neonatal white matter damage and long-term cognitive deficits caused by hyperoxia. | Q52148099 | ||
| Total radical-trapping antioxidant parameter in NIDDM patients. | Q52275754 | ||
| Oxidative damage to mitochondria at the nodes of Ranvier precedes axon degeneration in ex vivo transected axons. | Q52651477 | ||
| Patients with multiple sclerosis show increased oxidative stress markers and somatic telomere length shortening. | Q53001350 | ||
| [Antioxidant use as dietary therapy in patients with multiple sclerosis]. | Q53633461 | ||
| Effects of a low-fat diet with antioxidant supplementation on biochemical markers of multiple sclerosis long-term care residents. | Q54311255 | ||
| Erythrocytes' antioxidative capacity as a potential marker of oxidative stress intensity in neuroinflammation. | Q54545951 | ||
| Peroxynitrite Mediated Oxidation of Purine Bases of Nucleosides and Isolated DNA | Q56919077 | ||
| Evidence for possible role of melatonin in reducing oxidative stress in multiple sclerosis through its effect on SIRT1 and antioxidant enzymes | Q57258966 | ||
| Hemoglobin as a source of iron overload in multiple sclerosis: does multiple sclerosis share risk factors with vascular disorders? | Q57898104 | ||
| Differentiation block of oligodendroglial progenitor cells as a cause for remyelination failure in chronic multiple sclerosis | Q61415557 | ||
| Free radicals in the physiological control of cell function | Q27860480 | ||
| Inflammation, Iron, Energy Failure, and Oxidative Stress in the Pathogenesis of Multiple Sclerosis | Q28080754 | ||
| Antioxidant enzymes and human diseases | Q28142812 | ||
| The molecule of the year | Q28237487 | ||
| Multiple sclerosis | Q28299151 | ||
| Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly | Q29547442 | ||
| Axonal transection in the lesions of multiple sclerosis | Q29615585 | ||
| Reactive oxygen species, antioxidants, and the mammalian thioredoxin system | Q29619367 | ||
| Axonal pathology in multiple sclerosis: relationship to neurologic disability | Q30581941 | ||
| Endothelial function in hypertension: the role of superoxide anion | Q33752634 | ||
| The role of mitochondria in reactive oxygen species metabolism and signaling | Q33849198 | ||
| Tumor necrosis factor-α impairs oligodendroglial differentiation through a mitochondria-dependent process | Q33858402 | ||
| Melatonin acts as antioxidant and improves sleep in MS patients. | Q34006944 | ||
| Hydrogen peroxide in the human body. | Q34099983 | ||
| Human studies related to protein oxidation: protein carbonyl content as a marker of damage | Q34146688 | ||
| Autophagy of mitochondria: a promising therapeutic target for neurodegenerative disease | Q34287719 | ||
| Review: Mitochondria and disease progression in multiple sclerosis | Q34308687 | ||
| Cerebrospinal fluid ceramides from patients with multiple sclerosis impair neuronal bioenergetics | Q34422726 | ||
| Multiple sclerosis deep grey matter: the relation between demyelination, neurodegeneration, inflammation and iron | Q34607681 | ||
| Ozone autohemotherapy induces long-term cerebral metabolic changes in multiple sclerosis patients | Q34665153 | ||
| Astroglial PGC-1alpha increases mitochondrial antioxidant capacity and suppresses inflammation: implications for multiple sclerosis | Q34720644 | ||
| Involvement of oxidative stress in occurrence of relapses in multiple sclerosis: the spectrum of oxidatively modified serum proteins detected by proteomics and redox proteomics analysis | Q34769676 | ||
| Acrolein detection: potential theranostic utility in multiple sclerosis and spinal cord injury | Q34888636 | ||
| Oxidation of biological systems: oxidative stress phenomena, antioxidants, redox reactions, and methods for their quantification | Q35038985 | ||
| Oxidative damage in multiple sclerosis lesions | Q35065674 | ||
| Dimethyl fumarate modulates antioxidant and lipid metabolism in oligodendrocytes | Q35594174 | ||
| Relationship between the Increased Haemostatic Properties of Blood Platelets and Oxidative Stress Level in Multiple Sclerosis Patients with the Secondary Progressive Stage | Q35598836 | ||
| Tracking iron in multiple sclerosis: a combined imaging and histopathological study at 7 Tesla. | Q35606720 | ||
| NADPH oxidase expression in active multiple sclerosis lesions in relation to oxidative tissue damage and mitochondrial injury | Q35776944 | ||
| Dimethyl Fumarate Protects Neural Stem/Progenitor Cells and Neurons from Oxidative Damage through Nrf2-ERK1/2 MAPK Pathway | Q35814106 | ||
| Cell type-specific Nrf2 expression in multiple sclerosis lesions. | Q35856138 | ||
| Nigella sativa amliorates inflammation and demyelination in the experimental autoimmune encephalomyelitis-induced Wistar rats | Q35918951 | ||
| Attenuation of 7-ketocholesterol-induced overproduction of reactive oxygen species, apoptosis, and autophagy by dimethyl fumarate on 158N murine oligodendrocytes. | Q35938192 | ||
| Intranuclear matrix metalloproteinases promote DNA damage and apoptosis induced by oxygen-glucose deprivation in neurons | Q35987121 | ||
| Evaluation of Delta-Aminolevulinic Dehydratase Activity, Oxidative Stress Biomarkers, and Vitamin D Levels in Patients with Multiple Sclerosis | Q61780781 | ||
| Characterization of free radical generation by xanthine oxidase. Evidence for hydroxyl radical generation | Q69349215 | ||
| [Natalizumab and reduction of carbonylated proteins in patients with multiple sclerosis] | Q83854528 | ||
| Paraoxonase 1 activity in multiple sclerosis patients during mitoxantrone therapy | Q84769917 | ||
| [Cryostimulation as an antioxidative factor in sclerosis multiplex] | Q85080939 | ||
| Tolerability and Safety of Combined Glatiramer Acetate and N-Acetylcysteine in Relapsing-Remitting Multiple Sclerosis | Q85578184 | ||
| Oxidative modification of serum proteins in multiple sclerosis | Q85772565 | ||
| Serum ferroxidase activity in patients with multiple sclerosis: a pilot study | Q85965756 | ||
| Activity of liver enzymes in multiple sclerosis patients with Hot-nature diet and co-supplemented hemp seed, evening primrose oils intervention | Q86121374 | ||
| The patients with clinically isolated syndrome and relapsing remitting multiple sclerosis show different levels of advanced protein oxidation products and total thiol content in plasma and CSF | Q86410703 | ||
| α-Lipoic acid enhances endogenous peroxisome-proliferator-activated receptor-γ to ameliorate experimental autoimmune encephalomyelitis in mice | Q86526742 | ||
| Decreased concentration of Klotho in the cerebrospinal fluid of patients with relapsing-remitting multiple sclerosis | Q87103712 | ||
| Disability in patients with multiple sclerosis: influence of insulin resistance, adiposity, and oxidative stress | Q87209478 | ||
| Monomethylfumarate reduces in vitro migration of mononuclear cells | Q87248214 | ||
| Combined GSTP1 and NQO1 germline polymorphisms in the susceptibility to Multiple Sclerosis | Q87395533 | ||
| [Biochemical markers of oxidative stress in different forms and phases of multiple sclerosis] | Q95616724 | ||
| Chemical, pharmacokinetic and pharmacodynamic properties of statins: an update | Q36014966 | ||
| Dimethyl fumarate and the oleanane triterpenoids, CDDO-imidazolide and CDDO-methyl ester, both activate the Nrf2 pathway but have opposite effects in the A/J model of lung carcinogenesis | Q36067904 | ||
| Phasic Treatment with Interferon Gamma Stimulates Release of Exosomes that Protect Against Spreading Depression | Q36108513 | ||
| Saffron ethanolic extract attenuates oxidative stress, spatial learning, and memory impairments induced by local injection of ethidium bromide | Q36209917 | ||
| Treatment of a multiple sclerosis animal model by a novel nanodrop formulation of a natural antioxidant | Q36332494 | ||
| PRDX6 controls multiple sclerosis by suppressing inflammation and blood brain barrier disruption | Q36356190 | ||
| Acrolein-mediated injury in nervous system trauma and diseases | Q36452743 | ||
| Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research. | Q36457107 | ||
| Oxidative stress is related to the deleterious effects of heme oxygenase-1 in an in vivo neuroinflammatory rat model | Q36711785 | ||
| Comparative Analysis of Serum (Anti)oxidative Status Parаmeters in Healthy Persons | Q36790501 | ||
| Oxyl radicals, redox-sensitive signalling cascades and antioxidants | Q36849942 | ||
| Inhibition of Myeloperoxidase at the Peak of Experimental Autoimmune Encephalomyelitis Restores Blood-Brain-Barrier Integrity and Ameliorates Disease Severity. | Q36896738 | ||
| Repurposing the NRF2 Activator Dimethyl Fumarate as Therapy Against Synucleinopathy in Parkinson's Disease | Q37091371 | ||
| Nutraceuticals against Neurodegeneration: A Mechanistic Insight | Q37168739 | ||
| Neurodegeneration in multiple sclerosis: the role of oxidative stress and excitotoxicity | Q37236591 | ||
| New insights in the pathogenesis of multiple sclerosis--role of acrolein in neuronal and myelin damage | Q37291226 | ||
| IFNγ-stimulated dendritic cell exosomes as a potential therapeutic for remyelination | Q37576782 | ||
| Acrolein scavenging: a potential novel mechanism of attenuating oxidative stress following spinal cord injury | Q37603404 | ||
| Oxidative stress is differentially present in multiple sclerosis courses, early evident, and unrelated to treatment | Q37699846 | ||
| Exosomes for targeted siRNA delivery across biological barriers. | Q38037911 | ||
| Potential role of glucagon-like peptide-1 (GLP-1) in neuroprotection | Q38039489 | ||
| Progressive multiple sclerosis: pathology and pathogenesis | Q38046113 | ||
| Lipophilic fluorescent products of free radicals | Q38085166 | ||
| Dimethyl fumarate : a Janus-faced substance? | Q38108633 | ||
| Pathology and disease mechanisms in different stages of multiple sclerosis | Q38111904 | ||
| Central effects of GLP-1: new opportunities for treatments of neurodegenerative diseases | Q38133759 | ||
| Remote neurodegeneration: multiple actors for one play. | Q38179991 | ||
| Dimethyl fumarate: a review of its use in patients with relapsing-remitting multiple sclerosis | Q38195521 | ||
| The role of glutamate and its receptors in multiple sclerosis | Q38196367 | ||
| Mechanisms of neurodegeneration and axonal dysfunction in multiple sclerosis. | Q38196701 | ||
| The role of microglial activation in disease progression | Q38210510 | ||
| Glutathione in multiple sclerosis: more than just an antioxidant? | Q38212993 | ||
| Remote degeneration: insights from the hemicerebellectomy model | Q38254076 | ||
| Novel targets in multiple sclerosis: to oxidative stress and beyond | Q38283708 | ||
| Oxidative Stress and Neurobiology of Demyelination | Q38287176 | ||
| Pathological mechanisms in progressive multiple sclerosis | Q38378846 | ||
| Synthetic and natural inhibitors of phospholipases A2: their importance for understanding and treatment of neurological disorders | Q38428658 | ||
| Melatonin redox activity. Its potential clinical applications in neurodegenerative disorders | Q38488588 | ||
| Multiple Sclerosis Relapses: Epidemiology, Outcomes and Management. A Systematic Review. | Q38495935 | ||
| Melatonin: A Potential Anti-Oxidant Therapeutic Agent for Mitochondrial Dysfunctions and Related Disorders | Q38531064 | ||
| Over-the-counter anti-oxidant therapies for use in multiple sclerosis: A systematic review. | Q38569263 | ||
| The Deleterious Effects of Oxidative and Nitrosative Stress on Palmitoylation, Membrane Lipid Rafts and Lipid-Based Cellular Signalling: New Drug Targets in Neuroimmune Disorders. | Q38574561 | ||
| In vitro study of the direct effect of extracellular hemoglobin on myelin components | Q38933193 | ||
| Oxidants and human disease: some new concepts | Q39153422 | ||
| Alteration of prolyl oligopeptidase and activated α-2-macroglobulin in multiple sclerosis subtypes and in the clinically isolated syndrome. | Q39156437 | ||
| Multiple sclerosis: evaluation of purine nucleotide metabolism in central nervous system in association with serum levels of selected fat-soluble antioxidants | Q39933393 | ||
| Flavonoids inhibit myelin phagocytosis by macrophages; a structure-activity relationship study | Q40665129 | ||
| Dimethyl fumarate attenuates cerebral edema formation by protecting the blood-brain barrier integrity. | Q41336306 | ||
| The disruption of mitochondrial axonal transport is an early event in neuroinflammation | Q41966044 | ||
| Oxidative tissue injury in multiple sclerosis is only partly reflected in experimental disease models. | Q42260800 | ||
| Oxidative modification of blood serum proteins in multiple sclerosis after interferon or mitoxantrone treatment. | Q43916759 | ||
| TNF receptor 2 protects oligodendrocyte progenitor cells against oxidative stress | Q44237193 | ||
| Tumor necrosis factor is elevated in progressive multiple sclerosis and causes excitotoxic neurodegeneration | Q44251663 | ||
| Ceramide increases mitochondrial free calcium levels via caspase 8 and Bid: role in initiation of cell death | Q44299670 | ||
| Oxidative stress induced by lipid peroxidation is related with inflammation of demyelination and neurodegeneration in multiple sclerosis | Q44776045 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | multiple sclerosis | Q8277 |
| oxidative stress | Q898814 | ||
| pathophysiology | Q1135939 | ||
| physiological phenomenon | Q66615932 | ||
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | 1973834 | |
| P577 | publication date | 2016-01-01 | |
| 2016-10-18 | |||
| P1433 | published in | Oxidative medicine and cellular longevity | Q26840015 |
| P1476 | title | New Insights into the Role of Oxidative Stress Mechanisms in the Pathophysiology and Treatment of Multiple Sclerosis | |
| P478 | volume | 2016 |
| Q90721230 | Antioxidant Therapies for Neuroprotection-A Review |
| Q64259195 | Coenzyme Q10 supplementation reduces peripheral oxidative stress and inflammation in interferon-β1a-treated multiple sclerosis |
| Q93108868 | Differential Modulation of NF-κB in Neurons and Astrocytes Underlies Neuroprotection and Antigliosis Activity of Natural Antioxidant Molecules |
| Q60949388 | Genetic Association and Altered Gene Expression of in Multiple Sclerosis Patients |
| Q49829881 | Impaired Cardiac Function in Patients with Multiple Sclerosis by Comparison with Normal Subjects |
| Q95856653 | Inflammation and Oxidative Stress in Multiple Sclerosis: Consequences for Therapy Development |
| Q91647353 | Klotho Pathways, Myelination Disorders, Neurodegenerative Diseases, and Epigenetic Drugs |
| Q47719110 | Markers of oxidative/nitrative damage of plasma proteins correlated with EDSS and BDI scores in patients with secondary progressive multiple sclerosis. |
| Q98619283 | Metformin as a Potential Agent in the Treatment of Multiple Sclerosis |
| Q39350409 | Modulating inflammation and neuroprotection in multiple sclerosis |
| Q97523765 | Oxidative Damage of Blood Platelets Correlates with the Degree of Psychophysical Disability in Secondary Progressive Multiple Sclerosis |
| Q64251070 | Oxidative Stress Related to Iron Metabolism in Relapsing Remitting Multiple Sclerosis Patients With Low Disability |
| Q93192934 | Potential role of iron in repair of inflammatory demyelinating lesions |
| Q45338276 | Redox Regulation of Inflammatory Processes Is Enzymatically Controlled. |
| Q59807167 | Silent Free Fall at Disease Onset: A Perspective on Therapeutics for Progressive Multiple Sclerosis |
| Q92053010 | The Anti-Inflammatory Effect of Sulforaphane in Mice with Experimental Autoimmune Encephalomyelitis |
| Q64065809 | The Beneficial and Debilitating Effects of Environmental and Microbial Toxins, Drugs, Organic Solvents and Heavy Metals on the Onset and Progression of Multiple Sclerosis |
| Q43375909 | The Evaluation of Oxidative Stress Parameters in Serum Patients with Relapsing-Remitting Multiple Sclerosis Treated with II-Line Immunomodulatory Therapy. |
| Q90523941 | The S100B Inhibitor Pentamidine Ameliorates Clinical Score and Neuropathology of Relapsing-Remitting Multiple Sclerosis Mouse Model |
| Q91393729 | Vitamin D protects human melanocytes against oxidative damage by activation of Wnt/β-catenin signaling |
Search more.